Explore 3 Stock Ideas & Industry Insights Download Free Report

Diagnamed Holdings Corp.

Company price
0.03 CAD -0.01 ( 14.29%)
Last update at 2026-11-09T18:04:00Z
VOLUME
146996
Market Cap
9.14M

Momentum Score

…

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.03
Low
0.04
High
52 Week Price Range
0.02
Low
0.25
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Diagnamed Holdings Corp appears to be a healthcare company focused on medical diagnostics, though public disclosure and detailed filings are limited. Its long-term growth may depend on broader demand for diagnostic services, adoption of new testing technologies and successful geographic or product expansion. Investors may find exposure to small-cap healthcare upside attractive if the company can demonstrate clinical validation and commercial traction.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.04
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-292.41%
Net Debt
-
ROCE
330.95%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Type yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Income before tax -1.40M -0.50M -1.28M -1.13M
Net income -1.40M -0.50M -1.28M -1.13M
Selling general administrative 0.61M 0.43M 0.82M 0.57M
Operating income -1.49M -0.74M -1.25M -1.14M
Interest income 0.00M 0.01M 0.01M 0.00M
Net interest income 0.00M 0.01M 0.01M 0.00M
Total revenue 0.00M 0.00M 0.00M 0.00M
Total operating expenses 1.49M 0.74M 1.25M 1.14M
Total other income expense net 0.08M 0.23M -0.03M 0.00M
Net income from continuing ops -1.40M -0.50M -1.28M -1.13M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Type yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total assets 0.22M 0.20M 0.66M 1.62M
Total liab 0.67M 0.47M 0.43M 0.37M
Total stockholder equity -0.45M -0.27M 0.24M 1.25M
Capital stock 4.28M 3.57M 3.57M 3.17M
Retained earnings -6.26M -4.86M -4.36M -3.08M
Cash 0.18M 0.16M 0.61M 1.57M
Total current liabilities 0.67M 0.47M 0.43M 0.37M
Total current assets 0.22M 0.20M 0.66M 1.62M
Net receivables 0.02M 0.03M 0.06M 0.05M
Non current assets total 0.00M 0.00M 0.00M 0.00M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Type yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total cash from financing activities 0.36M 0.00M 0.10M 0.00M
Net income -1.40M -0.50M -1.28M -1.13M
Change in cash 0.02M -0.44M -0.96M -0.79M
Begin period cash flow 0.16M 0.61M 1.57M 2.36M
End period cash flow 0.18M 0.16M 0.61M 1.57M
Total cash from operating activities -0.34M -0.44M -1.07M -0.79M
Issuance of capital stock - - - 0.00M
Change to account receivables 0.01M 0.02M -0.01M -0.01M
Capital expenditures 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.35M 0.27M 0.15M 0.21M
Stock based compensation 0.30M 0.00M 0.01M 0.14M
Other non cash items 0.52M - - -
Free cash flow -0.34M -0.44M -1.07M -0.79M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
DMED
Diagnamed Holdings Corp.
-0.01
14.29%
0.03 - - - 10.74 -1.43
AIDR
Rocket Doctor AI Inc
-0.01
1.06%
0.47 - - 1671.77 6.46 -0.39
NARA
Pangenomic Health Inc.
-
-%
0.30 - - - 5.38 -0.11
AIML
AI/ML Innovations Inc
-
-%
0.04 - - 70.85 35.17 -3.59
UDOC
UniDoc Health Corp.
0.01
11.11%
0.05 - - 10.64 668.99 -9.56

Profile*

Diagnamed Holdings Corp.

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.

82 Richmond Street East, Toronto, ON, Canada, M5C 1P1

416 800 2684

Name Title Year Born
Mr. Andre Turmel Independent Executive Chairman NA
Mr. John Karagiannidis President, CEO & Director NA
Mr. Edward Low Chief Financial Officer NA
Mr. Andrew Newbury CPA Corporate Secretary NA
Mr. Edward Low Interim Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…